Effects of alprazolam on the development of Moloney sarcoma virus-induced tumors in stressed mice. 1996

M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
Neuroimmunology University of Santiago, School of Pharmacy, Santiago de Compostela, Spain.

Experiments were conducted to evaluate the effects of alprazolam (1 mg/kg i.p.) on the development of autochthonous tumors induced by the Moloney sarcoma virus (MSV) in BALB/c female mice subjected to stress. Enhancement of MSV-induced tumor incidence and growth was observed, together with a delay in the usual prompt regression of the tumors, when programmed white sound anxiety-stress was administered immediately following MSV i.m. inoculation. However, a depressant effect on tumor size and incidence was observed when stress was administered before virus inoculation. Treatment with alprazolam was found to reverse partially the adverse effects of postinoculation stress, and also to inhibit the beneficial effects of the preinoculation administration of stress on tumor development. Pretreatment with Ro 15-1788 (10 mg/kg s.c.), a central benzodiazepine antagonist, resulted in a suppression on both effects of alprazolam in stressed mice.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008980 Moloney murine sarcoma virus A replication-defective murine sarcoma virus (SARCOMA VIRUSES, MURINE) isolated from a rhabdomyosarcoma by Moloney in 1966. Moloney Sarcoma Virus,Sarcoma Virus, Moloney,Virus, Moloney Sarcoma
D009622 Noise Any sound which is unwanted or interferes with HEARING other sounds. Noise Pollution,Noises,Pollution, Noise
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D005260 Female Females
D005442 Flumazenil A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses. Flumazepil,Anexate,Lanexat,Ro 15-1788,Romazicon,Ro 15 1788,Ro 151788
D000525 Alprazolam A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) Alprazolan,Alprox,Apo-Alpraz,Cassadan,D-65MT,Esparon,Kalma,Novo-Alprazol,Nu-Alpraz,Ralozam,Tafil,Trankimazin,U-31,889,Xanax,Apo Alpraz,D65MT,Novo Alprazol,Nu Alpraz,U31,889
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012192 Retroviridae Infections Virus diseases caused by the RETROVIRIDAE. Retrovirus Infections,Infections, Retroviridae,Infections, Retrovirus,XMRV Infection,Xenotropic MuLV-related Virus Infection,Xenotropic Murine Leukemia Virus-related Virus Infection,Infection, Retroviridae,Infection, Retrovirus,Infection, XMRV,Infections, XMRV,Retroviridae Infection,Retrovirus Infection,XMRV Infections,Xenotropic MuLV related Virus Infection,Xenotropic Murine Leukemia Virus related Virus Infection
D012513 Sarcoma, Experimental Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA. EHS Tumor,Sarcoma, Engelbreth-Holm-Swarm,Sarcoma, Jensen,Experimental Sarcoma,Experimental Sarcomas,Sarcomas, Experimental,Engelbreth-Holm-Swarm Sarcoma,Jensen Sarcoma,Sarcoma, Engelbreth Holm Swarm,Tumor, EHS

Related Publications

M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
June 1974, Prostaglandins,
M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
December 1969, Cancer research,
M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
September 1967, Cancer research,
M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
September 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
February 1981, International journal of cancer,
M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
May 1970, International journal of cancer,
M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
April 1973, Cancer research,
M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
July 1972, Cancer research,
M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
January 1977, Immunological communications,
M Freire-Garabal, and M J Núñez-Iglesias, and J L Balboa, and J C Fernández-Rial, and L García-Vallejo, and M Rey-Méndez
May 1969, Cancer research,
Copied contents to your clipboard!